BIOMAT Database Logo BIOMAT Database Logo

[Autoimmune hemolytic anemia in a Parkinsonian treated with a combination of L-dopa and carbidopa]. 1977

M Barat, and P Conte, and J Hilaire, and L Arne

UI MeSH Term Description Entries
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D002230 Carbidopa An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself. Methyldopahydrazine,Carbidopa, (R)-Isomer,Carbidopa, (S)-Isomer,Lodosin,Lodosyn,MK-485,MK-486,MK 485,MK 486,MK485,MK486
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000744 Anemia, Hemolytic, Autoimmune Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS. Anemia, Hemolytic, Idiopathic Acquired,Autoimmune Haemolytic Anaemia,Autoimmune Hemolytic Anemia,Cold Agglutinin Disease,Hemolytic Anemia, Autoimmune,Acquired Autoimmune Hemolytic Anemia,Anemia, Hemolytic, Cold Antibody,Cold Antibody Disease,Cold Antibody Hemolytic Anemia,Idiopathic Autoimmune Hemolytic Anemia,Agglutinin Disease, Cold,Anaemia, Autoimmune Haemolytic,Anemia, Autoimmune Hemolytic,Autoimmune Haemolytic Anaemias,Autoimmune Hemolytic Anemias,Cold Agglutinin Diseases,Cold Antibody Diseases,Haemolytic Anaemia, Autoimmune

Related Publications

M Barat, and P Conte, and J Hilaire, and L Arne
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
January 1979, Clinical science (London, England : 1979),
M Barat, and P Conte, and J Hilaire, and L Arne
Autoimmune hemolytic anemia in relation to L-dopa therapy.
January 1972, The American journal of medical technology,
M Barat, and P Conte, and J Hilaire, and L Arne
Mental symptoms in Parkinsonian patients treated with L-dopa.
July 1970, Lancet (London, England),
M Barat, and P Conte, and J Hilaire, and L Arne
Mental symptoms in parkinsonian patients treated with L-dopa.
October 1970, Lancet (London, England),
M Barat, and P Conte, and J Hilaire, and L Arne
Functional evaluation of Parkinsonian patients treated with L-dopa.
January 1970, Canadian journal of occupational therapy. Revue canadienne d'ergotherapie,
M Barat, and P Conte, and J Hilaire, and L Arne
Dopamine/L-dopa ratio in cerebrospinal fluid of parkinsonian patients treated with L-dopa + benserazide.
January 1984, Psychopharmacology,
M Barat, and P Conte, and J Hilaire, and L Arne
Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
February 1973, Diseases of the nervous system,
M Barat, and P Conte, and J Hilaire, and L Arne
Autoimmune hemolytic anemia in a child treated with thymectomy.
July 1970, The Tohoku journal of experimental medicine,
M Barat, and P Conte, and J Hilaire, and L Arne
[A case of L-dopa induced autoimmune hemolytic anemida].
October 1985, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M Barat, and P Conte, and J Hilaire, and L Arne
Clinical trial of carbidopa-L-dopa combination for cocaine abuse.
November 1986, The American journal of psychiatry,
Copied contents to your clipboard!